StockData
UNITED THERAPEUTICS Corp logo

UNITED THERAPEUTICS Corp (UTHR) stock

UTHRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3022% above fair value
$584.10−3.78 (-0.64%)

Close on Nov 17, 2026Market cap $25.05BP/E 20.9Yield –

United Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

For fiscal 2013 it was $3.72M, down 94.7% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2013Dec 31, 2013$3.72M-94.7%
FY2012Dec 31, 2012$70.34M-1.6%
FY2011Dec 31, 2011$71.45M+3.7%
FY2010Dec 31, 2010$68.93M–

More United Therapeutics figures

See a number that looks wrong?